StockNews.AI
ANIK
StockNews.AI
174 days

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

1. Anika will release Q4 2024 financial results on March 12, 2025. 2. An investor conference call is scheduled for the same day at 5 p.m. ET. 3. Anika focuses on orthopedic care and joint preservation advancements. 4. Their expertise includes osteoarthritis pain management and regenerative solutions. 5. Live audio webcast of the call will be available on Anika's website.

Earnings
-0.73%Current Return
VS
-1.37%S&P 500
$17.7102/26 08:49 AM EDTEvent Start
$17.580102/27 03:42 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings releases typically generate investor interest. Positive financial results could boost stock demand.

How important is it?

Earnings announcements can significantly affect stock pricing due to investor sentiment and growth potential.

Why Short Term?

The impact will be felt immediately post-earnings release announcement. Historical data shows stock price reactions following quarterly reports.

Related Companies

VRTXAVEOIDRA
February 26, 2025 08:00 ET  | Source: Anika Therapeutics Inc. BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2024 financial results after the close of the market on Wednesday, March 12, 2025 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 89368. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion. About AnikaAnika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com. ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc. For Investor Inquiries:Anika Therapeutics, Inc.Matt Hall, 781-457-9554Director, Corporate Development and Investor Relationsinvestorrelations@anika.com

Related News